Tag: RGDX

Blue Horseshoe Stocks: ABIO Recap & More

ARCA BioPharma, Inc. ABIO

Our top performer from yesterday’s report was most assuredly ABIO. We tagged this play after noticing that it had announced being granted orphan drug status by the FDA for “rNAPc2” as a potential treatment of viral hemorrhagic fever post-exposure to the Ebola virus.

Fresh FDA-related plays can often provide a healthy move to take advantage of, and that’s just what we got from ABIO, The stock traded in a range from .82-1.03, an intraday increase of 25% on nearly ten times the 3-month average volume.

Our long-time readers might recall our coverage of this stock last year in December, which sort of got lost in the shuffle that was the hysteria created by the “Green Rush”. We tracked the stock from the low 1.40’s to over 2.20 over a period of a few weeks, so it will be interesting to see if history continues to repeat itself with ABIO, especially with the stock coming off of it 52-week low on Tuesday.

CYREN Ltd. CYRN

We also wanted to acknowledge the early morning move made by another of the stocks we mentioned in yesterday’s newsletter, CYRN. It bolted out of the gate, quickly running from 2.22 to 2.67, a 20% spike within the first 15 minutes of the session.

The stock got hammered into the close quite a bit, so we’ll be open to the possibility of seeing some bounce action, provided it can hold support at or above the 50DMA of 1.75.

Office Depot, Inc. ODP

ODP is in the midst of making a big move on the heels of large activist investor Starboard Value taking up a position which equates to 6% of ODP’s total shares. It also upped its stake in Staples to 10% fueling speculation that it could create pressure for the two office supply giants to merge. It will definitely be a story that we’ll be interested to follow moving forward.

Extended Watchlist:
GPT, RGDX, CYTX, DRD

Blue Horseshoe Stocks: Updates on LWSP, TTDZ & PBR

Legacy Platinum Group, Inc. LWSP
–
We’d like to update everyone on the status of one of this week’s successful picks. We first brought LWSP to our readers on Tuesdaymorning, at which time the stock opened up at .187.LWSP spent the next two sessions on the upswing, culminating in yesterday’s push to  a new high of .33. That marks a three-day overall increase of 76%

Moving forward, we’ll need to see support hold at or above .21 in order for us to remain interested in LWSP.

Remember, per Tuesday’s PR, we’re waiting for an upcoming name and symbol change, expected to begin on May 16th.  We’ll also be on the lookout for further updates from the company on its new direction in the e-cigarette and portable vaporizer market.

Triton Distribution Systems, Inc. TTDZ

For some of our newer readers, allow us to do a quick recap of how TTDZ has become one of 2014’s superstar picks for us. Beginning with our first alert on the stock on January 30th, we observed a low of .0012. and it has been pushing its upper boundaries ever since.

By the time mid-March rolled around, the stock had punched above .015, gaining well over 1200% from our first call, but the party was just getting started.

Flash forward to the present, and TTDZ has pressed its way all the way to an impressive high of .0385. Which means that in less than two months, we’ve seen a total increase of 3108% out of TTDZ.

This is another play that recently transitioned into the cannabis sector that has applied for a name and symbol change, and we expect to have an update on that within the next few weeks.

Petroleo Brasiliero SA (Petrobras) PBR

After picking up on PBR exactly two weeks ago today, we’ve seen some impressive trading action in that short time, especially with regard to the options chain.

Besides coming across this stock shortly after it hit all-time lows, and witnessing the start of one heck of a recovery, we also received news this week of PBR’s boosted production numbers from February, which were significantly higher than those of previous months.

Today we’ll be looking at the $13 and $13.50 Weekly Calls for possible intraday flip-opportunities. For those without the ability to stay glued to your screens all day, for longer-term possibilities, we’ve noted our interest in the May $12 Calls and the April $14 Calls.

In the event that PBR fails to hold support at or above the 13-dollar mark, we would have to reassess our opinions.

Extended Watchlist:
UDHI (News), LATF (Financials), JRJC, RGDX, ROSG, USAT, ZGNX

Blue Horseshoe Stocks: MNKD, ANGI & Extended Watchlist

MannKind Corp. MNKD
–
In putting MNKD on bottom-watch in Friday’s Report, we gave folks the chance to catch this play at a subsequent low of 3.85 on Monday.

We were then hit with the news concerning recommendation from an FDA advisory panel to green-light one of the company’s drugs, after hours on Monday which led to a significant gap-up yesterday.

It appears as if the stock will gap up for the second consecutive session today. In pre-market trading thus far, MNKD has pushed into the 7.30’s. From the low we saw just a couple of days ago to this morning’s high (7.33), represents an overall increase of 90%

Angie’s List, Inc. ANGI

Speaking of recovery plays, ANGI is coming off of a recent bottom, and the resurgence of the share price is opening up some avenues of opportunity with regard to the options chain.

Currently on our radar are the 05/17 $15 Calls, which closed at .65 yesterday, and the 04/19 $12.50 Calls, which last traded at 1.03.

A quick look at the 6-month ANGI chart reveals a stock with the ability to make big swings. We can see that from December through January it ran from the $12-range to the $19-range with ferocity. It would appear as if we are catching it at the beginning of another swing. The RSI is rising sharply, and we’ve got a confirmed uptrend off of that bottom with higher lows and higher highs having been achieved over the past three sessions.

The potential for gains, not only with the options, but also on the stock side of things, is something that we’ll be looking for as we track ANGI during its recovery.

Extended Watchlist:
GLGT, TFER, AMRS, RGDX, ANTH,